Haw Financial Statements From 2010 to 2025
| HAWPF Stock | USD 8.00 0.00 0.00% |
Check Haw ParLimited financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Haw ParLimited's main balance sheet or income statement drivers, such as , as well as many indicators such as . Haw financial statements analysis is a perfect complement when working with Haw ParLimited Valuation or Volatility modules.
Haw |
Haw Par Company Profit Margin Analysis
Haw ParLimited's Profit Margin measures overall efficiency of a company and shows its ability to withstand competition as well as defend against adverse conditions such as rising costs, falling prices, decline in sales or management distress. Profit margin tells investors how well the company executes on its overall pricing strategies as well as how effective the company in controlling its costs.
Current Haw ParLimited Profit Margin | 0.79 % |
Most of Haw ParLimited's fundamental indicators, such as Profit Margin, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Haw Par is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
In a nutshell, Profit Margin indicator shows the amount of money the company makes from total sales or revenue. It can provide a good insight into companies in the same sector, as well as help to identify trends of a company from year to year.
| Competition |
Based on the latest financial disclosure, Haw Par has a Profit Margin of 0.7862%. This is 107.01% lower than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—General industry. The profit margin for all United States stocks is 161.91% lower than that of the firm.
Haw ParLimited Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Haw ParLimited's current stock value. Our valuation model uses many indicators to compare Haw ParLimited value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Haw ParLimited competition to find correlations between indicators driving Haw ParLimited's intrinsic value. More Info.Haw Par is one of the top stocks in return on equity category among its peers. It also is one of the top stocks in return on asset category among its peers reporting about 0.15 of Return On Asset per Return On Equity. The ratio of Return On Equity to Return On Asset for Haw Par is roughly 6.73 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Haw ParLimited's earnings, one of the primary drivers of an investment's value.About Haw ParLimited Financial Statements
Haw ParLimited stakeholders use historical fundamental indicators, such as Haw ParLimited's revenue or net income, to determine how well the company is positioned to perform in the future. Although Haw ParLimited investors may analyze each financial statement separately, they are all interrelated. For example, changes in Haw ParLimited's assets and liabilities are reflected in the revenues and expenses on Haw ParLimited's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Haw Par. Please read more on our technical analysis and fundamental analysis pages.
Haw Par Corporation Limited, together with its subsidiaries, manufactures, markets, and trades in healthcare products in Singapore, ASEAN countries, other Asian countries, and internationally. The company was incorporated in 1969 and is based in Singapore. Haw Par operates under Drug ManufacturersGeneral classification in the United States and is traded on OTC Exchange.
Currently Active Assets on Macroaxis
Other Information on Investing in Haw Pink Sheet
Haw ParLimited financial ratios help investors to determine whether Haw Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Haw with respect to the benefits of owning Haw ParLimited security.